The Egyptian Journal of Internal Medicine

Table 1 Baseline demographics, duration of dialysis, and access in three studied groups

From: Different vitamin K forms in hemodialysis patients: a simple dietary supplement to battle vascular calcification—randomized controlled trial

		Groups
		Vitamin K1	Vitamin K2	Placebo
Age (years)	Range	21–67	20–70	18–66	F: 0.53	P-value: 0.59
Age (years)	Mean ±SD	47.35±14.42	46.2 ±14.73	49.5±14.51	F: 0.53	P-value: 0.59
Gender	Male,N(%)	18 (45%)	20 (50%)	16 (40%)	X²: 0.808	P-value: 0.668
Gender	Female,N(%)	22 (55%)	20 (50%)	24 (60%)	X²: 0.808	P-value: 0.668
Duration of dialysis (years)	Range	1.5–16	1–20	0.5–15	F: 1.858	P-value: 0.161
Duration of dialysis (years)	Mean ±SD	5.263±3.158	6.738±4.496	5.281–4.008	F: 1.858	P-value: 0.161
Access	AV fistula N(%)	38 (95%)	37 (92.5%)	37 (92.5%)	X²: 0.268	P-value: 0.875
Access	Permicath,N(%)	2 (5%)	3 (7.5%)	3 (7.5%)	X²: 0.268	P-value: 0.875

Back to article page